Maximizing trEatment of Neurological Dysfunction Using INtravenous Guanfacine Study

Clinical trial NCT04742673 · COMPLETED

Trial details

NCT number: NCT04742673
Sponsor: Vanderbilt University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Critical Illness Delirium Cognitive Impairment

Start date: 2021-05-04
Primary completion: 2024-03-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.